![]() The Heli-FX and Heli-FX Thoracic EndoAnchor systems have CE mark for distribution in the European Union and are cleared by the U.S. "The Heli-FX and Heli-FX Thoracic EndoAnchor systems strongly align with our strategy to invest in treatments that address complex aortic disease with a vision to treat disease of the entire aorta." "We are excited to add this unique complementary, anchor technology to our aortic portfolio," said Daveen Chopra, vice president and general manager of the aortic business, within the Cardiac and Vascular Group at Medtronic. This may include patients with challenging anatomies, risk factors for a secondary intervention, existing seal complications, as well as in situations where a physician may intraoperatively determine the need for additional security. The off-the-shelf, customized solution minimizes the need for complicated procedures for the select subset of patients who would benefit from supplementary fixation, according to Medtronic. During the procedure, a minimally invasive catheter-based system is used to implant a metal and fabric endograft to isolate blood flow away from the aneurysm to prevent potential rupture and death.Īptus Endosystems' Heli-FX and Heli-FX Thoracic EndoAnchor systems feature an endovascular deployed anchor designed to attach a variety of aortic endografts to the native vessel wall. EVAR and TEVAR procedures are alternatives to open surgical repair of aortic aneurysms. ![]() and 100,000 people in Europe are diagnosed with AAA. Each year, an estimated 200,000 people in the U.S. An estimated 1.5 million Americans have an abdominal aortic aneurysm (AAA). Additional terms of the acquisition were not disclosed.Īortic aneurysms are an enlarged and weakened section of the aorta, the main artery carrying blood from the heart, which can be lethal if left untreated. ![]() ![]() Medtronic completed its acquisition of the assets of Aptus Endosystems in a transaction valued at approximately $110 million. Medtronic plc has acquired the assets of Aptus Endosystems Inc., a Sunnyvale, Calif.-based, privately held developer of advanced technology for endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR). ![]()
0 Comments
Leave a Reply. |